PMC6681253_01
PET scan axial view, 1 year post diagnosis, pre-PARP inhibitor treatment.
Blue arrow shows large liver metastasis.
10.1177_2324709619864989-fig1.jpg
PMC6681253_01_10.1177_2324709619864989-fig1.jpg
fig1-2324709619864989
PET scan at this time showed these to be hypermetabolic with no extra hepatic metastasis (see Figures 1 and 2, showing large PET avid liver lesions).
PET scan coronal view, 1 year after diagnosis, prior to PARP inhibitor
treatment. Thick and thin arrows showing liver metastasis.
10.1177_2324709619864989-fig2.jpg
PMC6681253_01_10.1177_2324709619864989-fig2.jpg
fig2-2324709619864989
PET scan at this time showed these to be hypermetabolic with no extra hepatic metastasis (see Figures 1 and 2, showing large PET avid liver lesions).
PET scan 3 months post-PARP inhibitor. No metastasis seen in the liver.
10.1177_2324709619864989-fig3.jpg
PMC6681253_01_10.1177_2324709619864989-fig3.jpg
fig3-2324709619864989
PET scan coronal view, 3 months post-PARP inhibitor treatment. No liver
metastasis seen.
10.1177_2324709619864989-fig4.jpg
PMC6681253_01_10.1177_2324709619864989-fig4.jpg
fig4-2324709619864989